Pier Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.09M Buy
+57,392
New +$8.18M 1.17% 28

Other funds holding PTGX

Pier Capital's PTGX Position: Q3 2026 in Review

Pier Capital opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 57,392 shares worth $8.09M. The stake represents 1.17% of the portfolio and ranks #28 among its holdings.

379 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Pier Capital held 57,392 shares of Protagonist Therapeutics worth $8.09M as of Q3 2026.
  • Protagonist Therapeutics was a new Pier Capital position in Q3 2026.
  • Protagonist Therapeutics made up 1.17% of Pier Capital's portfolio in Q3 2026, its #28 holding.
  • 379 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Pier Capital's 13F filing for Q3 2026, filed 13 Nov 2026.